KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Preferred Shares (2020 - 2025)

LifeMD (LFMD) has disclosed Preferred Shares for 6 consecutive years, with $140.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Preferred Shares changed 0.0% year-over-year to $140.0, compared with a TTM value of $140.0 through Dec 2025, changed 0.0%, and an annual FY2025 reading of $140.0, changed 0.0% over the prior year.
  • Preferred Shares was $140.0 for Q4 2025 at LifeMD, roughly flat from $140.0 in the prior quarter.
  • Across five years, Preferred Shares topped out at $140.0 in Q4 2021 and bottomed at $140.0 in Q4 2021.
  • Average Preferred Shares over 5 years is $140.0, with a median of $140.0 recorded in 2021.
  • Peak annual rise in Preferred Shares hit 0.0% in 2022, while the deepest fall reached 0.0% in 2022.
  • Year by year, Preferred Shares stood at $140.0 in 2021, then changed by 0.0% to $140.0 in 2022, then changed by 0.0% to $140.0 in 2023, then changed by 0.0% to $140.0 in 2024, then changed by 0.0% to $140.0 in 2025.
  • Business Quant data shows Preferred Shares for LFMD at $140.0 in Q4 2025, $140.0 in Q3 2025, and $140.0 in Q2 2025.